N-3 polyunsaturated fatty acid therapy improves endothelial function and affects adiponectin and resistin balance in the first month after myocardial infarction

Archives of Medical Science

Volumn 7, Issue 5, 2011, Pages 788-795

  Mizia Stec, Katarzyna ^a   Haberka, Maciej ^a   Mizia, Magdalena ^a   Chmiel, Artur ^a   Gieszczyk, Klaudia ^a   Lasota, Bartosz ^a   Janowska, Joanna ^a   Zahorska Markiewicz, Barbara ^a   Ga̧sior, Zbigniew ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Adiponectin; Endothelial function; Myocardial infarction; Polyunsaturated fatty acids; Resistin

Indexed keywords

ACETYLSALICYLIC ACID; ADIPONECTIN; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; OMEGA 3 FATTY ACID; RESISTIN;

ACUTE HEART INFARCTION; ADULT; ANTICOAGULANT THERAPY; ARTERY BLOOD FLOW; ARTERY DIAMETER; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY STENT; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTRAVASCULAR ULTRASOUND; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PARATHYROID HORMONE BLOOD LEVEL; PATIENT COMPLIANCE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; WAIST CIRCUMFERENCE;

EID: 81555222772     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/aoms.2011.25553     Document Type: Article

References (28)

1. Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002; 105: 1897-903. (Pubitemid 34437615)
2. Barylski M, Mikhailidis DP, Rysz J, Banach M. Non-pharmacological management after acute coronary syndromes. Arch Med Sci 2010; 6 (1A): S64-75.
3. Gajos G, Rostoff P, Undas A, Piwowarska W. Effects of polysaturated omega-3 fatty acids on responsiveness to dual antiplateles therapy in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol 2010; 55: 1671-8.
4. Fichtlscherer S, Breuer S, Zeiher A. Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes. Further evidence for the existence of the "vulnerable" patient. Circulation 2004; 110: 1926-32. (Pubitemid 39331903)
5. Vitale C, Cerquetani E, Wajngarten M, et al. In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy. Ital Heart J 2003; 4: 627-32.
6. Petersen MM, Eschen RB, Aardestrup I, Obel T, Schmidt EB. Flow-mediated vasodilatation and dietary intake of n-3 polyunsaturated acids in healthy subjects. Cell Mol Biol 2010; 56: 38-44.
7. Lee KW, Blann AD, Lip GY. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes. Int J Cardiol 2006; 111: 302-8. (Pubitemid 44107573)
8. Rizza S, Tesauro M, Cardillo C, et al. Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes. Atherosclerosis 2009; 206: 569-74.
9. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006; 296: 1885-99. (Pubitemid 44596197)
10. Karra R, Becker RC. Biomarkers for outcome following acute coronary syndromes. Arch Med Sci 2010; 6 (1A): S55-S63.
11. Lyon CJ, Law RJ, Hsueh WA. Minireview: adiposity, inflammation, and atherogenesis. Endocrinology 2003; 144: 2195-200. (Pubitemid 36629866)
12. Karastergiou K, Mohamed-Ali V, Jahangiri M, Kaski JC. Adiponectin for prediction of cardiovascular risk? Br J Diabetes Vasc Dis 2009; 9: 150-4.
13. Karmazyn M, Purdham DM, Rajapurohitam V, Zeidan A. Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart. Cardiovasc Res 2008; 79: 279-86. (Pubitemid 351951616)
14. Kojima S, Funahashi T, Sakamoto T, et al. The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction. Heart 2003; 89: 667-8. (Pubitemid 36606220)
15. Piestrzeniewicz K, Łuczak K, Goch JH. Factors associated with C-reactive protein at the early stage of acute myocardial infarction in men. Cardiol J 2009; 16: 36-42.
16. Gao J, Chang Chua C, Chen Z, et al. Resistin, an adipocytokine, offers protection against acute myocardial infarction. J Mol Cell Cardiol 2007; 43: 601-9.
17. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow mediated vasodilatation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257-65. (Pubitemid 34084631)
18. Stillwell W, Wassall SR, Docosahexaenoic acid: membrane properties of a unique fatty acid. Chem Phys Lipids 2003; 126: 1-27. (Pubitemid 37297962)
19. Okuda Y, Kawashima K, Sawada T, et al. Eicosapentanoic acid enhances nitric oxide production by cultured human endothelial cells. Biochem Biophys Res Comm 1997; 232: 487-91. (Pubitemid 27216245)
20. Ayer JG, Harmer JA, David C, Steinbeck K, Seale JP, Celermajer DS. Severe obesity is associated with impaired arterial smooth muscle function in young adults. Obesity 2011; 19: 54-60.
21. Mizia-Stec K, Gasior Z, Zahorska-Markiewicz B, et al. The indexes of arterial structure and function in women with simple obesity: a preliminary study. Heart Vessels 2008; 23: 224-9.
22. Kawanami D, Maemura K, Takeda N, et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem Biophys Res Commun 2004; 314: 415-19. (Pubitemid 38084733)
23. Verma S, Li SH, Wang CH, et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 2003; 108: 736-40. (Pubitemid 36999260)
24. Nakamura Y, Shimada K, Fukuda D, et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart 2004; 90: 528-33. (Pubitemid 38530170)
25. Qiao XZ, Yang YM, Xu ZR, Yang LA. Relationship between resistin level in serum and acute coronary syndrome or stable angina pectoris. J Zhejiang Univ Sci B 2007; 8: 875-80.
26. Patel JV, Lee KW, Tomson J, Dubb K, Hughes EA, Lip GY. Effects of omega-3 polyunsaturated fatty acids on metabolically active hormones in patients post-myocardial infarction. Int J Cardiol 2007; 115: 42-5. (Pubitemid 44856752)
27. Ramel A, Martinéz A, Kiely M, Morais G, Bandarra NM, Thorsdottir I. Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults. Diabetologia 2008; 51: 1261-8.
28. Micallef MA, Garg ML. Anti-inflammatory and cardioprotective effects of n-3 polyunsaturated fatty acids and plant sterols in hyperlipidemic individuals. Atherosclerosis 2009; 204: 476-82.